Selection and pathogenicity of Candida albicans in HIV infection

Oral Diseases

Volumn 3, Issue SUPPL. 1, 1997, Pages

  Sweet, S P ^a,b  

^a UMDS   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Adherence; Candida albicans; Hyphae; Oral candidosis; Protease; Switching; Thigmotropism; Virulence

Indexed keywords

CANDIDA ALBICANS; CONFERENCE PAPER; CONTROLLED STUDY; DNA FINGERPRINTING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUTH MUCOSA; PHENOTYPE; PRIORITY JOURNAL; THRUSH; VIRUS VIRULENCE;

EID: 0030979162     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1997.tb00383.x     Document Type: Conference Paper

References (90)

1. Agatensi L, Franchi F, Mondello F et al (1991). Vaginopathic and proteolytic Candida species in outpatients attending a gynaecology clinic. J Clin Pathol 44: 826-830.
2. Alaei S, Larcher C, Ebenbichler C et al (1993). Isolation and biochemical characterization of the iC3b receptor of Candida albicans. Infect Immun 61: 1395-1399.
3. Anthony RM, Midgley J, Sweet SP et al (1995). Multiple strains of Candida albicans in the oral cavity of HIV positive and HIV negative patients. Microb Ecol Hlth Dis 8: 23-30.
4. Arendorf TM, Walker DM (1979). Oral candidal populations in health and disease. Br Dent J 147: 267-272.
5. Arendorf TM, Walker DM (1980). The prevalence and intraoral distribution of Candida albicans. Arch Oral Biol 25: 1-10.
6. Brawner DL, Cutler JE (1989). Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome. J Clin Microbiol 27: 1335-1341.
7. Bruatto M, Vidotto V, Marinuzzi G et al (1991). Candida albicans biotypes in human immunodeficiency virus type 1-infected patients with oral candidiasis before and after antifungal therapy. J Clin Micro 29: 726-730.
8. Calderone RA, Scheld WM (1987). Role of fibronectin in the pathogenesis of candidal infections. Rev Infect Dis 9: S400-S403.
9. Challacombe SJ (1990). Immunology of oral candidosis. In: Samaranayake LP, MacFarlane TW, eds. Oral candidosis. Wright: London, pp 104-123.
10. Challacombe SJ, Muir J, Howell SA et al (1995). Genetic variability of Candida albicans in HIV infection. Microbial Ecol Health Dis 8: 63-70.
11. Chaturvedi VP, Vanegas R, Chaffin WL (1994). Coordination of germ tube formation and surface antigen expression in Candida albicans. FEMS Micro Letters 124: 99-105.
12. Chavanet P, Lopez J, Grappin M et al (1994). Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients. AIDS 8: 945-950.
13. Coleman DC, Bennett DE, Gallagher PJ et al (1995). Oral candidiasis and HIV infection: antifungal drug resistance and changes in Candida population dynamics. In: Greenspan JS, Greenspan D, eds. Oral Manifestations of HIV Infection. Quintessence Publishing Co, Inc: Chicago, pp 112-118.
14. Coleman DC, Bennett DE, Sullivan DJ et al (1993). Oral Candida in HIV infection and AIDS: new perspectives/new approaches. Crit Reviews Microbiol 19: 61-82.
15. Collins-Lech C, Kalbfleisch JH, Franson TR et al (1984). Inhibition by sugars of Candida albicans adherence to human buccal mucosal cells and corneocytes in vitro. Infect Immun 46: 831-834.
16. Coogan MM, Sweet SP, Challacombe SJ (1994). Immunoglobulin A (IgA), IgA1, and IgA2 antibodies to Candida albicans in whole and parotid saliva in human immunodeficiency virus infection and AIDS. Infect Immun 62: 892-896.
17. Critchley IA, Douglas LJ (1987a). Isolation and partial characterization of an adhesin from Candida albicans. J Gen Microbiol 133: 629-636.
18. Critchley LA, Douglas LJ (1987b). Role of glycosides as epithelial cell receptors for Candida albicans. J Gen Microbiol 133: 637-643.
19. De Bernardis F, Boccanera M, Rainaldi L et al (1992). The secretion of aspartyl proteinase, a virulence enzyme, by isolates of Candida albicans from the oral cavity of HTV-infected subjects. Eur J Epidemiol 8: 362-367.
20. De Bernardis F, Chiani P, Ciccozzi M et al (1996). Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus. Infect Immun 64: 466-471.
21. Ener B, Douglas LJ (1992). Correlation between cell-surface hydrophobicity of Candida albicans and adhesion to buccal epithelial cells. FEMS Micro Lets 78: 37-42.
22. Fox R, Neal KR, Leen CL et al (1991). Fluconazole resistant candida in AIDS. J Infection 22: 201-204.
23. Ghannoum MA, Burns GR, Elteen KA et al (1986). Experimental evidence for the role of lipids in adherence of Candida spp. to human buccal epithelial cells. J Infect Dis 54: 189-193.
24. Gibbons RJ, van Houte J (1975). Bacterial adherence in oral microbial ecology. A Rev Microbiol 29: 19-44.
25. Gilmore BJ, Retsinas EM, Lorenz JS et al (1987). An iC3b receptor on Candida albicans: structure, function and correlates for pathogenicity. J Infect Dis 157: 38-46.
26. Gottlieb MS, Schanker HM, Fan PT et al (1981). Pneumocystis pneumonia - Los Angeles. MMWR 30: 250-251.
27. Gow NA, Perera TH, Sherwood-Higham J et al (1994). Investigation of touch-sensitive responses by hyphae of the human pathogenic fungus Candida albicans. Scanning Microscopy 8: 705-710.
28. Hoffman MP, Haidrais CG (1993). Analysis of Candida albicans adhesion to salivary mucin. Infect Immun 61: 31-38.
29. Imbert-Bernard C, Valentin A, Mallie M et al (1995). Involvement of Candida albicans cell wall proteins in the adherence of blastospores to human buccal epithelial cells. Exper Mycol 19: 247-253.
30. Kaminishi H, Miyaguchi H, Tamaki T et al (1995). Degradation of humoral host defense by Candida albicans proteinase. Infect Immun 63: 984-988.
31. Kanbe T, Han Y, Redgrave B et al (1993). Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue. Infect Immun 61: 2578-2584.
32. Keating J, Bjarnason I, Somasundaram S et al (1995). Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut 37: 623-639.
33. Kilian M, Mestecky J, Russell MW (1988). Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by immunoglobulin A proteases. Microbiol Rev 52: 296-303.
34. Klein RS, Harris CA, Small CB et al (1984). Oral candidosis in high risk patients and the clinical manifestations of the acquired immune deficiency syndrome. New Eng J Med 311: 354-357.
35. Klotz SA, Hein RC, Smith RL et al (1994). The fibronectin adhesin of Candida albicans. Infect Immun 62: 4679-4681.
36. Korting HC, Ollert M, Georgii A et al (1989). In vitro susceptibilities and biotypes of Candida albicans isolates from oral cavities of persons infected with HIV. J Clin Microbiol 26: 2626-2631.
37. Krause W, Matheis H, Wulf K (1969). Fungaemia and funguria after oral administration of Candida albicans. Lancet 1: 598-599.
38. Kwon-chung KJ, Lehman D, Good C et al (1985). Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun 49: 571-575.
39. Lal K, Pollock JJ, Santarpia RP et al (1992). Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity. J AIDS 5: 904-914.
40. Langford-Kuntz AA, Ruchel R, Reichart PA (1988). Oral manifestations of candidiasis in HIV-infected patients. Clinical and microbiological studies. Deutsche Zeitschrift fur Mund-, Kiefer-, und Gesichts-Chirurgie 12: 28-35.
41. Lehrer N, Segal E, Lis H et al (1988). Effect of Candida albicans cell wall components on the adhesion of the fungus to human and murine vaginal mucosa. Mycopathol 102: 115-121.
42. Li RK, Cutler JE (1993). Chemical definition of an epitope/adhesin molecule on Candida albicans. J Biol Chem 268: 18293-18299.
43. Lupetti A, Guzzi G, Paladini A et al (1995). Molecular typing of Candida albicans in oral candidiasis: karyotype epidemiology with human immunodeficiency virus-seropositive patients in comparison with that with healthy carriers. J Clin Microbiol 33: 1238-1242.
44. MacDonald F, Odds FC (1983). Virulence for mice of a proteinase-secreting strain of Candida albicans and a proteinase-deficient mutant. J Gen Microbiol 129: 431-438.
45. Mandel ID, Barr CE, Turgeon L (1992). Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 21: 209-213.
46. McCullough MJ, Ross BC, Dwyer BD et al (1994). Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology 140: 1195-1202.
47. Miyakawa Y, Kuribayashi T, Kagaya K et al (1992). Role of specific determinants in mannan of Candida albicans serotype A in adherence to human buccal epithelial cells. Infect Immun 60: 2493-2499.
48. Miyasaki SH, Hicks JB, Greenspan D et al (1992). The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals. J AIDS 5: 1039-1046.
49. Monod M, Togni G, Hube B et al (1994). Multiplicity of genes encoding secreted aspartic proteinases in Candida species. Molecular Microbiol 13: 357-368.
50. Müller F, Frøland SS, Brandtzaeg P et al (1993). Oral candidiasis is associated with low levels of parotid calprotectin in individuals with infection due to human immunodeficiency virus. Clin Infect Dis 16: 301-302.
51. Negi M, Tsuboi R, Matsui T et al (1984). Isolation and characterization of proteinase from Candida albicans: substrate specificity. J Invest Dermatol 83: 32-36.
52. Okamoto K, Ashimoto A, Tanaka Y et al (1993). Germ tube formation and proteinase activity of Candida albicans in relation to virulence for mice. J Jap Assoc Infect Dis 67: 466-472.
53. Ollert MW, Wende C, Gorlich M et al (1995). Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol 33: 2543-2549.
54. Palmer GD, Robinson PG, Challacombe SJ et al (1996). Aetiological factors for oral manifestations of HIV. Oral Dis 2: 193-197.
55. Persi MA, Burnham JC, Duhring JL (1985). Effects of calcium dioxide and pH on adhesion of C. albicans to vaginal epithelial cells. Infect Immun 50: 82-90.
56. Phelan JA, Salzman BR, Friedland GH et al (1987). Oral findings in patients with acquired immune deficiency syndrome. Oral Surg. 64: 50-56.
57. Powderly WG (1992). Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients. AIDS 6: 604-605.
58. Powderly WG, Robinson K, Keath EJ (1992). Molecular typing of Candida albicans isolated from oral lesions of HIV-infected individuals. AIDS 6: 81-84.
59. Qureshi MN, Barr CE, Seshamma T et al (1995). Infection of oral mucosal cells by human immunodeficiency virus type 1 in seropositive persons. J Infect Dis 171: 190-193.
60. Rajasingham KC (1993). TEM studies of oral and vaginal candidosis. Microscopy Analysis September: 15-17.
61. Rams TE, Andriolo MJ, Feik D et al (1991). Microbiological study of HIV-related periodontitis. J Periodontol 62: 74-81.
62. Ray TL, Payne CD, Morrow BJ (1991). Candida albicans acid proteinase: characterization and role in candidiasis. Adv Exp Med Biol 306: 173-183.
63. Redding S, Smith J, Farinacci G et al (1994). Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clini Infect Dis 18: 240-242.
64. Reichart PA, Philipsen HP, Schmidt-Westhausen A et al (1995). Pseudomembranous oral candidiasis in HIV infection: ultrastructural findings. J Oral Pathol Med 24: 276-281.
65. Ruchel R (1986). Cleavage of immunoglobulins by pathogenic yeasts of the genus Candida. Microbiol Sci 3: 316-319.
66. Samaranayake LP, MacFarlane TW (1982). Factors affecting the in vitro adherence of the fungal oral pathogen Candida albicans to epithelial cells of human origin. Arch Oral Biol 27: 869-873.
67. Samaranayake LP, MacFarlane TW (1990). Oral candidosis. Butterworth & Co. Ltd.: London.
68. Samaranayake YH, Wu PC, Samaranayake LP et al (1995). Relationship between the cell surface hydrophobicity and adherence of Candida krusei and Candida albicans to epithelial and denture acrylic surfaces. APMIS 103: 707-713.
69. Sandin RL (1987). Studies of cell adhesion and concanavalin A-induced agglutination of Candida albicans after mannan extraction. J Med Microbiol 24: 145-150.
70. Sandin RL, Rogers AL, Patterson RJ et al (1982). Evidence for mannose-mediated adherence of Candida albicans to human buccal cells in vitro. Infect Immun 35: 79-85.
71. Schiodt M (1992). HIV-associated salivary gland disease: a review. Oral Surg Oral Med Oral Path 73: 164-167.
72. Schmid J, Odds FC, Wiselka MJ et al (1992). Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J Clin Microbiol 30: 935-941.
73. Schmidt-Westhausen A, Fehrenbach FJ, Reichart PA (1990). Oral Enterobacteriaceae in patients with HIV infection. J Oral Path Med 19: 229-231.
74. Schmidt-Westhausen A, Schiller A, Pohle HD et al (1991). Oral Candida and Enterobacteriaceae in HIV-1 infection: correlation with clinical candidiasis and antimycotic therapy. J Oral Pathol Med 20: 469-472.
75. Segal E, Lehrer N, Ofek I (1982). Adherence of C. albicans to human vaginal epithelial cells: inhibition by amino sugars. Exp Cell Biol 59: 13-17.
76. Sherwood J, Gow NA, Gooday GW et al (1992). Contact sensing in Candida albicans: a. possible aid to epithelial penetration. J Med Vet Mycology 30: 4610-469.
77. Slutsky B, Buffo J, Soll DR (1985). High-frequency switching of colony morphology in Candida albicans. Science 230: 666-669.
78. Soil DR (1992). High-frequency switching in Candida albicans. Clin Microbiol Rev 5: 183-203.
79. Soll DR (1995). A molecular approach to the role of switching in oral candidiasis. In: Greenspan JS, Greenspan D, eds. Oral Manifestations of HIV Infection. Quintessence Publishing Co, Inc: Chicago, pp 93-102.
80. Soll DR, Galask R, Schmid J et al (1991). Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol 29: 1702-1710.
81. Soll DR, Staebell M, Langtimm C et al (1988). Multiple Candida strains in the course of a single systemic infection. J Clin Microbiol 26: 1448-1459.
82. Stellbrink HJ, Albrecht H, Fenske S et al (1992). Candida krusei sepsis in HIV infection. AIDS 6: 746-748.
83. Sullivan DJ, Westerneng TJ, Haynes KA et al (1995). Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141: 1507-1521.
84. Sweet SP, Cookson S, Challacombe SJ (1995). Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells. J Med Microbiol 43: 452-457.
85. Sweet SP, Douglas LJ (1991). Effect of iron deprivation on surface composition and virulence determinants of Candida albicans. J Gen Micro 137: 859-865.
86. Togni G, Sanglard D, Monod M (1994). Acid proteinase secreted by Candida tropicalis: virulence in mice of a proteinase negative mutant. J Med Vet Mycol 32: 257-265.
87. Tosh DF, Douglas LJ (1992). Characterisation of a fucose binding adhesin of Candida albicans. Infect Immun 60: 4734-4739.
88. Whelan WL, Kirsch DR, Kwon-Chung KJ et al (1990). Candida albicans in patients with acquired immunodeficiency syndrome: absence of a novel or hypervirulent strain. J Infect Dis 162: 513-518.
89. White TC, Agabian N (1995). Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J Bacteriol 177: 5215-5221.
90. White TC, Pfaller MA, Rinaldi MG et al (1997). Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. Oral Dis 3 (Suppl 1): S102-S109.